Calendar Roche Holding AG

Equities

ROG

CH0012032048

Market Closed - Swiss Exchange 12:30:28 2024-03-28 pm EDT 5-day change 1st Jan Change
229.7 CHF +1.30% Intraday chart for Roche Holding AG +2.07% -6.05%

Chart calendar Roche Holding AG

5fd5ea02a892c9e7da1e3fb63e2028.vdadmxiEGnK5ONFnmYMy-5hztFqi7exkeEeg_9DiYiY.xK-l7SjDUxX-aKYM_vlXw_871zOWpYcuPi_SmYaXMFyIlfCjQuF2GPdBkA~b922a285ff98558ffa1178c664ce7504

Upcoming events on Roche Holding AG

2024-04-24 01:00 am Q1 2024 Sales and Revenue Release
2024-04-24 08:00 am Q1 2024 Sales and Revenue Call
2024-05-14 01:00 pm BofA Securities Health Care Conference
2024-05-15 03:00 am Berenberg Diagnostics Conference
2024-05-22 07:00 am Investor Day
2024-05-22 07:30 am Investor Day
2024-05-23 02:00 am Deutsche Bank dbAccess European Champions Conference
2024-05-29 08:00 am Bernstein Strategic Decisions Conference
2024-06-05 08:00 am Jefferies Healthcare Conference
2024-06-06 02:00 am Vontobel Swiss Equity Leadership Conference
2024-06-06 02:00 am BNP Paribas Exane CEO Conference
2024-06-11 08:00 am Goldman Sachs Global Healthcare Conference
2024-06-18 03:00 am Citi European Healthcare Conference
2024-07-25 01:00 am Q2 2024 Earnings Release
2024-07-25 08:00 am Q2 2024 Earnings Call

Past events on Roche Holding AG

2024-03-26 04:00 am BNP Exane Healthcare Conference
2024-03-21 04:00 am Kepler Cheuvreux Swiss Seminar
2024-03-13 Ex-dividend day for final dividend
2024-03-12 10:00 am Barclays Global Healthcare Conference
2024-03-12 05:30 am Annual General Meeting
2024-03-11 10:00 am Investor Meeting - Neurology
2024-03-10 HIMSS Conference
2024-03-06 10:00 am TD Cowen Health Care Conference
2024-02-27 03:00 am UBS European Healthcare Conference
2024-02-24 American Academy of Allergy, Asthma & Immunology Meeting
2024-02-22 12:00 pm Citi Oncology Leadership Summit
2024-02-01 08:00 am Q4 2023 Earnings Call
2024-02-01 01:00 am Q4 2023 Earnings Release
2024-01-11 04:00 am Octavian Seminar
2024-01-09 11:00 am JPMorgan Healthcare Conference
2023-12-12 12:00 pm American Society of Hematology Meeting
2023-12-12 02:00 am BNPP Exane DILS CEO Conference
2023-12-11 09:00 pm American Society of Hematology Meeting - Abstract Number: #4090
2023-12-11 09:00 pm American Society of Hematology Meeting - Abstract Number: #4088
2023-12-11 09:00 pm American Society of Hematology Meeting - Abstract Number: #3999

Past dividends on Roche Holding AG

2024-03-13 Annual 9.6 CHF
2023-03-15 Annual 9.5 CHF
2022-03-16 Annual 9.3 CHF
2021-03-17 Annual 9.1 CHF
2020-03-18 Annual 9 CHF
2019-03-06 Annual 8.7 CHF
2018-03-14 Annual 8.3 CHF
2017-03-15 Annual 8.2 CHF
2016-03-02 Annual 8.1 CHF
2015-03-04 8 CHF

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million CHF
Released
Forecast
Spread
61 466
61 789
-0.52%
58 323
59 276
-1.61%
62 801
62 237
0.91%
63 281
63 332
-0.08%
58 716
59 502
-1.32%

59 591

EBITDA
Million CHF
Released
Forecast
Spread
25 419
24 199
5.04%
24 281
24 532
-1.02%
24 692
25 569
-3.43%
25 015
24 644
1.51%
21 976
22 765
-3.46%

22 659

EBIT
Million CHF
Released
Forecast
Spread
22 479
22 680
-0.89%
21 536
21 622
-0.4%
21 897
22 784
-3.89%
22 173
22 200
-0.12%
19 240
19 957
-3.59%

19 852

Earnings before Tax (EBT)
Million CHF
Released
Forecast
Spread
16 614
18 369
-9.56%
17 965
18 289
-1.77%
17 398
20 328
-14.41%
16 327
19 694
-17.1%
14 079
17 867
-21.2%

17 440

Net income
Million CHF
Released
Forecast
Spread
13 497
14 257
-5.33%
14 295
14 335
-0.28%
13 930
15 065
-7.53%
12 421
14 442
-13.99%
11 498
13 584
-15.35%

13 073

EPS
CHF
Released
Forecast
Spread
15,6
16,6
-5.73%
16,5
16,5
-0.02%
16,2
17,8
-9.22%
15,4
17,9
-14.08%
14,3
17,0
-15.74%

16,2

Announcement Date30/01/2004/02/2103/02/2202/02/2301/02/24-

Quarterly results

Fiscal PeriodDecember 2019 S2 2020 S1 2020 S2 2021 S1 2021 Q4 2021 S2 2022 Q1 2022 Q2 2022 S1 2022 Q3 2022 Q4 2022 S2 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2023 S2 2024 Q1 2024 Q2 2024 S1 2024 Q3 2024 Q4 2024 S2 2025 Q1 2025 S1 2025 S2
Net sales
Million CHF
Released
Forecast
Spread
30 997
31 426
-1.37%
29 281
30 369
-3.58%
29 042
30 037
-3.31%
30 713
30 038
2.25%
16 117
15 745
2.36%
32 088
31 791
0.93%
16 445
16 072
2.32%
15 850
15 474
2.43%
32 295
31 869
1.34%
14 742
15 274
-3.48%
16 244
16 102
0.88%
30 986
30 807
0.58%
15 322
15 011
2.07%
14 457
14 534
-0.53%
29 779
29 914
-0.45%
14 274
14 256
0.13%

14 938

28 937
29 318
-1.3%

14 515


14 540


28 952


14 690


15 015


30 163


15 320


30 630


30 615

EBIT
Million CHF
Released
Forecast
Spread
10 116
10 525
-3.89%
11 766
11 824
-0.49%
9 770
9 915
-1.46%
11 652
11 715
-0.53%



10 245
11 539
-11.21%






12 668
12 024
5.35%






9 505
9 639
-1.39%






10 911
11 057
-1.32%






8 329
9 168
-9.15%







10 208








9 950










Earnings before Tax (EBT)
Million CHF
Released
Forecast
Spread
6 260
9 758
-35.85%
10 181
10 632
-4.24%
7 784
9 124
-14.68%
9 887
10 773
-8.22%



7 511
10 155
-26.04%






10 985
11 047
-0.56%






5 342
9 016
-40.75%






9 174
10 510
-12.71%






4 905
8 786
-44.17%







8 621








8 619










Net income
Million CHF
Released
Forecast
Spread
4 878
6 896
-29.26%
8 079
8 713
-7.27%
6 216
7 084
-12.25%
7 803
8 526
-8.48%



6 127
7 703
-20.46%






8 530
8 216
3.82%






3 891
6 862
-43.3%






7 137
7 896
-9.61%






4 361
6 781
-35.69%







6 496








6 630










EPS
CHF
Released
Forecast
Spread
5,63
7,56
-25.53%
9,32
9,70
-3.92%
7,20
8,06
-10.64%
9,05
9,29
-2.58%



7,15
9,30
-23.12%






10,5
10,0
5.14%






4,83
7,87
-38.6%






8,87
9,42
-5.81%






5,44
8,43
-35.47%







8,09








8,26










Announcement Date30/01/2023/07/2004/02/2122/07/2103/02/2203/02/2225/04/2221/07/2221/07/2218/10/2202/02/2302/02/2327/04/2327/07/2327/07/2301/11/23-01/02/24---------

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise